Allergan buys LifeCell for $2.9 billion

San Antonio-based global biotech company Acelity LP has sold one of its business units to Botox maker Allergan for $2.9 billion in cash. Allergan plc (NYSE: AGN), which was based in Irvine, California, until it was bought by Dublin-based Actavis Plc last year, will use Acelity’s LifeCell business unit as its entry point into regenerative medicine. "The acquisition of LifeCell is both strategically and financially compelling to A llergan and serves as our entry point into regenerative medicine…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news